Patent ID: 6479033
Filing Date: 2002-11-12
Classification: A61K,A61P

Abstract:
A composition for the treatment of tumors, which comprises(a) at least one cytostatic drug component in a PEG-, immuno-, or immuno/PEG liposome, together with (b) an embolizing agent of at least one of (i) starch particles or degradable starch particles lyophilized from a solution of starch, whereby the solution has a concentration of about 5 mg/ml to 70 mg/ml, wherein said particle range in size from 40 &mgr;m to 90 &mgr;m and are suspended in a physiological salt solution, (ii) gelatine, or (iii) nanoparticle, and (c) a contrasting agent containing at least one of iodine, gadolinium, and magnetite.